SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1806Prolia approved. After hours action seems strangely muted to me, considering hotuck-6/1/2010
1805is it really down this month on the Teva stuff?mopgcw-5/26/2010
1804zacks: Amgen Beats but Tones Down Outlook by: Zacks.com April 22, 2010 Amgen mopgcw-4/23/2010
1803seekingalpah: Amgen Inc. Q1 2010 Earnings Call Transcript April 22, 2010 | aboutmopgcw-4/22/2010
1802Amgen’s First Quarter 2010 Adjusted Earnings Per Share Increased 20 Percent to $JGoren-4/21/2010
1801zacks: Amgen Inc. (AMGN) should have a strong presence at the upcoming annual memopgcw-4/16/2010
1800CS: Amgen Inc. (AMGN) OUTPERFORM M. Aberman CP: US$ 57.38 TP: US$ 70 CAP: US$ 57mopgcw-2/22/2010
1799New Prolia PDUFA date for osteoporosis is 7/25/10: siliconinvestor.comDewDiligence_on_SI-2/19/2010
1798CS: Amgen Inc. (AMGN) OUTPERFORM M. Aberman CP: US$ 56.48 TP: US$ 70 CAP: US$ 56mopgcw-2/16/2010
1797:-)DewDiligence_on_SI-2/11/2010
1796That's an easy recommendation!tom pope-2/10/2010
1795<i>>While we are bullish on denosumab, any hiccup, either with respect DewDiligence_on_SI12/10/2010
1794Zacks: Amgen Inc. (AMGN) received a boost recently when the company announced pomopgcw-2/10/2010
1793CS: Amgen Inc. (AMGN) OUTPERFORM M. Aberman CP: US$ 57.46 TP: US$ 70 CAP: US$ 57mopgcw-2/9/2010
1792CS: Amgen Inc. (AMGN) OUTPERFORM M. Aberman CP: US$ 55.71 TP: US$ 70 CAP: US$ 56mopgcw-1/26/2010
1791seekingAplha CC Transcript: Amgen, Inc. (AMGN) Q4 2009 Earnings Call January 25,mopgcw-1/26/2010
1790AMGN is a value trap, IMHO. Other than denosumab, AMGN’s drug portfolio is long DewDiligence_on_SI-1/25/2010
1789as an uninformed value investor amgn seems incredibly cheap trading at 11X 2010 Madharry-1/25/2010
1788CS: Amgen Inc. (AMGN) OUTPERFORM M. Aberman CP: US$ 56.25 TP: US$ 70 CAP: US$ 56mopgcw-1/19/2010
1787I'll call it a tie between the Amgen and Novartis owners. I'd give firstuck21/13/2010
1786<i>>I think that's the shallowest SeekingAlpha analysis I've evDewDiligence_on_SI-1/13/2010
1785I probably would not disagree, but I like to keep track of things that challengemopgcw-1/13/2010
1784Looks like he FoundOmegasteve kammerer-1/13/2010
1783I think that's the shallowest SeekingAlpha analysis I've ever seen. Chetuck-1/13/2010
1782SeekingAplha: Amgen as a Short Candidate by: Andrew Horowitz January 13, 2010 mopgcw-1/13/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News